Lannett Enters Into Distribution Agreement For Levothyroxine

PHILADELPHIA, July 8, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into a future exclusive supply and distribution agreement for the approved Levothyroxine Sodium Tablets USP of Ce... Biopharmaceuticals, Generics, Distribution Lannett Company, Levothyroxine, Cediprof, Neolpharma Pharmaceutical Group
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news